Empire State Development

SimpliFed is a telehealth company founded in 2020 that offers virtual breastfeeding support to new and pregnant parents. The company focuses on providing accessible care during the peri and postnatal periods, addressing the challenges faced by parents, including sleep deprivation and concerns about infant nutrition. SimpliFed specializes in lactation and baby feeding support, as well as monitoring high-risk conditions such as hypertension and gestational diabetes. Through secure online and video-based connections, patients can engage with care navigators who guide them through their maternal care journey, helping them obtain quick answers to their questions about their infants' dietary needs.

The Rochester Technology and Manufacturing Association (RTMA) fosters manufacturing innovation and growth. By collaborating with businesses, academia, and government, RTMA helps the local manufacturing community.

Daystar Kids is a nonprofit organization that provides therapeutic, educational enrichment, and family support services.

RochesterWorks! is Monroe County's leading employment and training initiative, focused on fostering a robust workforce in the Rochester, NY area. The organization offers complimentary services to job seekers, youth, and businesses through two full-service Career Centers located at 255 North Goodman Street and 276 Waring Road. RochesterWorks! provides various workforce services, including recruitment, assessment, placement, and training for businesses, while also connecting them to federally-funded employment and training programs. This comprehensive approach aims to streamline the hiring process for employers, ultimately saving them time and resources.

Envisagenics, Inc. is a biotechnology company founded in 2013 and headquartered in Huntington, New York. It specializes in the development of a predictive analytics platform aimed at accelerating the discovery of RNA therapeutics. The company leverages advanced artificial intelligence and machine learning algorithms to analyze transcriptomic data, helping researchers identify and validate potential drug targets. Envisagenics' flagship technology, SpliceCore, is a cloud-based platform that utilizes RNA splicing analytics to predict drug targets and biomarkers, addressing the complexities of biomedical data. Given that over 30 million people in the U.S. suffer from genetic diseases or cancers related to RNA splicing errors, the company's mission is to streamline the development of innovative therapeutic solutions. By providing an in-silico RNA therapeutics discovery platform, Envisagenics enhances the efficiency of drug development processes, reducing time, cost, and risk associated with bringing new therapies to market through partnerships with biopharmaceutical companies.

FIFCO renders brewing, packaging, importing, marketing and selling services.

WISE Women’s Business Center provide comprehensive business training and counseling.

Dimensional Energy is a chemistry company focused on pioneering artificial photosynthesis to create environmentally friendly polymers and chemical intermediates. The company develops technology that utilizes and distributes sunlight in scalable reactor systems, effectively capturing and converting carbon dioxide into hydrocarbon fuels. By employing innovative waveguides, Dimensional Energy ensures even distribution of sunlight within its reactors, enhancing the reactivity of carbon dioxide molecules through functionalized catalysts. This approach aims to provide viable solar fuels, addressing critical energy needs while promoting sustainability.

Mohawk Valley EDGE is a nonprofit economic development agency located in Rome, New York. It plays a vital role in fostering economic growth in Oneida County by supporting the establishment and expansion of businesses and industries. The agency collaborates with both public and private sectors to create opportunities for new ventures, aiming to enhance the local economy. Managed by a board of members, Mohawk Valley EDGE coordinates various programs and resources designed to assist businesses in their growth and development initiatives.

Stark Truss Company is a building materials company that manufactures roof and floor trusses.

WCNY is Central New York’s public broadcasting company, providing great local and national programming, high-quality educational television.

Lidrotec is a company focused on enhancing the capabilities of production and manufacturing through the use of ultra-short pulse lasers. It has developed a specialized wafer dicing laser machine that employs ultrashort pulse processing technology. This innovative approach enables high-precision cutting, drilling, and structuring of various materials, particularly benefiting the semiconductor industry. By utilizing this advanced technology, Lidrotec aims to improve processing speeds while ensuring maximum accuracy in manufacturing processes.

LocalCoho is a farm-to-table fish company established in 2016 and based in Auburn, NY. The company specializes in providing sustainably sourced local fish to regional markets, with a focus on high-quality salmon. LocalCoho's salmon is derived from non-GMO, certified organic eggs and is raised responsibly, ensuring a product that is both flavorful and nutritious. The fish is characterized by its rich, reddish-orange meat and healthy oil content, offering customers a versatile and delicious seafood option.

Magnolia Neurosciences aims to discover and develop proprietary, selective, and drug-like small molecule therapeutics for the prevention of neuronal cell death, thereby providing novel treatment options for patients suffering from neurodegeneration and related conditions. Magnolia Neurosciences Corporation, created to pursue technologies developed at The University of Texas MD Anderson Cancer Center’s Therapeutics Discovery Division and the Neurodegeneration Consortium (NDC), is a New York-based Accelerator Life Science Partner portfolio company.

Petra Pharma Corporation is a clinical-stage pharmaceutical company based in New York that focuses on discovering and developing therapies targeting phosphoinositide (PI) signaling pathways. Established in 2015, the company aims to create novel small molecules that address serious medical conditions, particularly cancer and metabolic diseases. By honing in on unique enzyme targets involved in critical cellular processes such as cell division, growth, trafficking, and signaling, Petra Pharma seeks to develop innovative treatments that can enhance human health and provide new options for healthcare providers.